Dr. Alvarez’s primary focus is the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other malignancies of the female reproductive system. He holds a strong clinical interest in complicated gynecologic procedures and is adept at laparoscopic minimally invasive surgery. He also provides chemotherapy for patients with gynecologic cancers.
Dr. Alvarez designs and writes biologically-targeted phase II clinical research trials and has a particular interest in the fallopian tube as the site of cancer initiation in ovarian cancer. He is also focused upon recruiting patients to cancer center clinical trials and in procuring specimens in collaboration with basic-science researchers.
2279 45th Street
Sacramento, CA 95817
B.A., UC Berkeley, Berkeley, California, 1995
American Board of Obstetrics and Gynecology, Gynecologic Oncology,
Gynecologic Oncology Group Developmental Therapeutics
Society of Gynecologic Oncology
Select Recent Publications:
McCullough MC, Oh EE, Lucci JA 3rd, Alvarez EA. Ureteral-arterial fistula: A case report and review of the literature. Journal of Obstetrics and Gynaecology. 2012 Oct; 32(7): 617-20
Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecologic Oncology 2012 Aug;126(2):176-9.
Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Changing Demographics of Cervical Cancer in the United States (1973-2008). Gynecologic Oncology. 2012 Sep;126(3):330-3
Chen Y, Alvarez EA, Azzam D, Wander SA, Guggisberg N, Jordà M, Ju Z, Hennessy BT, Slingerland JM. Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo. Breast Cancer Res Treat. 2011 Jul; 128 (1): 69-78
Alvarez EA, Wolfson AH, Pearson JM, Crisp M, Mendez LE, Lambrou NC, Lucci JA 3rd. A phase I study of docetaxel as a radiosensitizer for locally advanced squamous cell cervical cancer. Gynecologic Oncology. 2009 May; 113(2): 195-9